Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family
暂无分享,去创建一个
M. Humbert | P. Corris | J. Egan | R. Trembath | J. Loyd | T. Higenbottam | W. Nichols | G. Elliott | N. Morgan | R. Machado | J. Gibbs | A. Peacock | L. Wheeler | J. Thomson | M. Pauciulo | K. Ward | Magdi S Yacoub | G. Mikhail | P. Rogers | John Newman | Agnes Crozier | R. Allcock | J. Newman
[1] R. Trembath,et al. Primary pulmonary hypertension: the pressure rises for a gene , 2000, Journal of clinical pathology.
[2] N. Fretwell,et al. A physical and transcript map based upon refinement of the critical interval for PPH1, a gene for familial primary pulmonary hypertension. The International PPH Consortium. , 2000, Genomics.
[3] H. Lodish,et al. Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.
[4] J. Massagué,et al. Controlling TGF-β signaling , 2000, Genes & Development.
[5] S. Hodge,et al. Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33. , 2000, American journal of respiratory and critical care medicine.
[6] H. Lodish,et al. Role of Transforming Growth Factor in Human Disease , 2000 .
[7] D. Marchuk. Genetic abnormalities in hereditary hemorrhagic telangiectasia , 1998, Current opinion in hematology.
[8] K. Miyazono,et al. HNPCC associated with germline mutation in the TGF-β type II receptor gene , 1998, Nature Genetics.
[9] K. Shroyer,et al. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. , 1998, The Journal of clinical investigation.
[10] W. Edwards,et al. Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases. , 1998, Mayo Clinic proceedings.
[11] S. Hodge,et al. Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32. , 1997, Circulation.
[12] N. D. Arnold,et al. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32 , 1997, Nature Genetics.
[13] J. Benichou,et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension , 1997 .
[14] J Benichou,et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. , 1996, The New England journal of medicine.
[15] M. Leppert,et al. Coancestry in apparently sporadic primary pulmonary hypertension. , 1995, Chest.
[16] V. Fuster,et al. Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. , 1993, British heart journal.
[17] S. Rich,et al. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.
[18] T. N. James,et al. Clinical and pathologic manifestations of pulmonary vascular disease in the toxic oil syndrome. , 1991, Journal of the American College of Cardiology.
[19] B. Groves,et al. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. , 1989, Circulation.
[20] R. Virmani,et al. Heterogeneity of pathologic lesions in familial primary pulmonary hypertension. , 1988, The American review of respiratory disease.
[21] D. Buff. Primary pulmonary hypertension. , 1987, Annals of internal medicine.
[22] E H Bergofsky,et al. Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.
[23] J. Newman,et al. Familial primary pulmonary hypertension: clinical patterns. , 1984, The American review of respiratory disease.